Hester Biosciences Limited

Web: hester.in NSE: HESTERBIO BSE: 524669 SECTOR: Healthcare - Pharmaceuticals & Biotechnology | Add Note | View Notes

2375 173(7%)

Volume

7k as on 23, Jun

Open

2,410

High

2,419

Low

2,365

2,202

VWAP

2,136

52 Week High

2,684

52 Week Low

1,239

Viand Research Rating

Quality Score

75/100

Growth Score

59/100

Valuation Score

50/100

Momentum Score

45/100

Analyst Recommendations

BUY/SELL

Hold | Buy | Strong Buy

Analyst Price Target

Market Cap (cr)

2,020

No. of Shares

0.85

P/E

69.78

P/B

6.79

Face Value

Div. Yield

Book Value (TTM)

CASH

DEBT

EPS (TTM)

ROE

9.73

ROCE

Profit Growth

Listing Date

13-Mar-15

Promoter Holding

53.73%

FII Holding

0.38%

DII Holding

Price Chart

Price Performance

1 Week3%

1 Month13%

3 Months57%

6 Months46%

1 Year46%

YTD46%

Moving Average

5 Day SMA2,091

10 Day SMA2,043

20 Day SMA2,018

30 Day SMA1,947

50 Day SMA1,796

61 Day SMA1,721

80 Day SMA0

200 Day SMA0

PIVOT LEVEL

	Standard	Camarilla	Fibonacci	Woodie's
Resistance 3	2,285	2,175	2,230	2,294
Resistance 2	2,230	2,167	2,193	2,234
Resistance 1	2,189	2,158	2,171	2,199
Pivot Point	2,135	2,149	2,135	2,139
Support 1	2,094	2,140	2,098	2,103
Support 2	2,040	2,132	2,076	2,044
Support 3	1,999	2,123	2,040	2,008

Competitors/Peers

#	Symbol	MCAP	LTP	1W	1M	6M	1Y	P/E	Ind PE	Debt/Eq	NP Qtr Rs.Cr.
1	SUNPHARMA	4,56,655	1899	0%	2%	9%	21%	37	57.7	0.07	11509
2	DIVISLAB	2,43,196	9161	2%	8%	44%	51%	69	57.7	0	2568
3	TORNTPHARM	1,84,303	4846	2%	3%	12%	36%	72	57.7	1.79	2138
4	APOLLOHOSP	1,24,834	8650	1%	1%	12%	10%	58	57.7	0.9	2003
5	ZYDUSLIFE	1,12,897	1132	4%	2%	26%	13%	20	57.7	0.46	5124
6	CIPLA	1,11,346	1385	2%	5%	3%	12%	22	57.7	0.02	3862
7	LAURUSLABS	99,634	1844	3%	3%	75%	114%	0	57.7	0.48	890
8	DRREDDY	96,962	1151	2%	2%	11%	8%	20	57.7	0.2	4158
9	MAXHEALTH	96,646	985	1%	10%	8%	14%	0	57.7	0.32	1442
10	LUPIN	96,620	2113	1%	11%	8%	10%	23	57.7	0.29	5355
Load More

Shareholding Pattern (%)

	Mar 2026	Dec 2025	Sep 2025	Jun 2025	Mar 2025	Dec 2024	Sep 2024	Jun 2024	Mar 2024	Dec 2023	Sep 2023	Jun 2023	Mar 2023	Dec 2022	Sep 2022	Jun 2022	Mar 2022	Dec 2021	Sep 2021
Promoters	(0.01) 53.73%	(0.01) 53.73%	(0.01) 53.73%	(0.01) 53.73%	(0.01) 53.73%	(0.01) 53.73%	(0.01) 53.73%	(0.01) 53.73%	(0.01) 53.73%	(0.01) 53.73%	(0.01) 53.73%	(0.01) 53.73%	(0.01) 53.73%	(0.01) 53.73%	(0.01) 53.73%	(0.01) 53.73%	(0.01) 53.73%	(0.01) 53.73%	(0.01) 53.73%
FIIs	(-0.11) 0.38%	(0.01) 0.52%	(0.01) 0.53%	(-0.41) 0.51%	(0.31) 0.87%	(0.01) 0.59%	(0.11) 0.61%	(0.11) 0.52%	(0.01) 0.43%	(0.01) 0.43%	(0.01) 0.42%	(0.01) 0.45%	(0.01) 0.45%	(-0.21) 0.45%	(-0.11) 0.62%	(-0.21) 0.72%	(0.11) 0.92%	(0.11) 0.80%	(0.01) 0.68%
DIIs	(0.01) 0.00%	(0.01) 0.01%	(0.01) 0.00%	(0.01) 0.02%	(0.01) 0.02%	(0.01) 0.02%	(0.01) 0.00%	(0.01) 0.00%	(0.01) 0.00%	(0.01) 0.00%	(0.01) 0.00%	(0.01) 0.00%	(0.01) 0.00%	(0.01) 0.03%	(0.01) 0.03%	(0.01) 0.04%	(0.01) 0.03%	(0.01) 0.02%	(0.01) 0.01%
Public	45.88%	45.75%	45.73%	45.73%	45.38%	45.65%	45.66%	45.74%	45.84%	45.83%	45.84%	45.82%	45.81%	45.77%	45.60%	45.51%	45.31%	45.45%	45.58%
No. of Shareholders	12,373	12,603	12,260	11,810	11,853	11,473	11,538	11,305	12,844	13,450	13,342	12,984	13,120	13,391	13,711	13,439	15,017	16,269	16,399

Quarterly Results

	Mar 2026	Dec 2025	Sep 2025	Jun 2025	Mar 2025	Dec 2024	Sep 2024	Jun 2024	Mar 2024	Dec 2023	Sep 2023	Jun 2023	Mar 2023	Dec 2022	Sep 2022	Jun 2022	Mar 2022	Dec 2021	Sep 2021	Jun 2021
Sales	100	77	71	84	82	63	84	82	79	67	70	88	67	74.94	73	51	56.47	56	62.66	60.19
Sales Growth % (YoY)	22.2%	22.5%	-15.2%	2.2%	3.4%	-5.6%	18.8%	-6.4%	17.8%	-10.6%	-3.7%	73.3%	19.2%	34.6%	16.7%	-15.8%	-12%	-2.1%	17.3%	51%
Sales Growth % (QoQ)	29.9%	8.5%	-15.5%	2.4%	30.2%	-25%	2.4%	3.8%	17.9%	-4.3%	-20.5%	31.3%	-10.6%	2.7%	43.1%	-9.7%	0.8%	-10.6%	4.1%	-
Expenses	66	60	59	61	63	58	65	65	63	57	57	73	56	56.18	60	43	46.15	41	45.1	43.12
Operating Profit	34	18	12	23	19	5	19	18	16	10	13	14	12	18.76	13	7	10.32	15	17.56	17.07
OPM %	34	23	17	27	23	8	23	21	20	15	19	16	17	25.03	17	15	18.28	27	28.02	28.36
Other Income	2	2	12	3	-6	9	3	2	5	2	6	3	3	6.37	5	5	7.62	3	1.42	2.35
Interest	5	2	2	2	6	-4	6	5	7	2	8	3	1	3.89	2	2	1.5	1	0.74	0.86
Depreciation	6	4	4	4	4	4	4	4	4	4	4	5	5	5.24	5	5	5.13	5	3.05	3.23
Profit before tax	25	14	17	20	4	13	12	11	10	6	7	9	8	16	10	5	11.31	12	15.19	15.33
Tax %	34	31	16	14	59	15	29	29	35	37	40	25	32	24	36	35	20.34	29	26.73	28.11
Net Profit	17	9	14	17	2	11	8	7	6	4	4	7	6	12.16	7	4	9	8	11.13	11.02
Net Profit Growth % (QoQ)	88.9%	-35.7%	-17.6%	750%	-81.8%	37.5%	14.3%	16.7%	50%	-	-42.9%	16.7%	-50.7%	73.7%	75%	-55.6%	12.5%	-28.1%	1%	-
Net Profit Growth % (YoY)	750%	-18.2%	75%	142.9%	-66.7%	175%	100%	-	-	-67.1%	-42.9%	75%	-33.3%	52%	-37.1%	-63.7%	-	-	-	-
TTM Net Profit	57	42	44	38	28	32	25	21	21	21	29.16	32.16	29.16	32.16	28	32.13	39.15	30.15	22.15	0
EPS in Rs	18.78	10.31	16.99	19.33	1.52	13.71	9.64	7.45	5.82	4.68	4.81	6.9	5.33	13.15	8.16	4.67	9.07	9.97	12.48	14.68

Profit and Loss

	Mar 2026	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019	Mar 2018	Mar 2017	Mar 2016	Mar 2015	Mar 2014	Mar 2013
Sales	333	311	305	266	235	214	183	178	136	123	101	90	69	65
Sales Growth %	6.9%	2.2%	14.4%	13.2%	9.6%	17%	2.9%	31%	10.4%	22.5%	12.1%	30.5%	5.8%	34.8%
Expenses	246	250	251	215	175	146	128	110	89	82	67	64	44	43
Operating Profit	87	62	54	51	60	69	55	68	47	41	34	25	24	22
OPM %	26	20	18	19	26	32	30	38	35	33	34	28	36	34
Other Income	19	8	15	20	14	1	6	7	3	0	1	3	1	0
Interest	11	13	20	9	4	7	7	7	4	4	4	5	6	3
Depreciation	19	17	17	21	17	13	13	12	10	7	6	6	5	4
Profit before tax	76	40	32	40	54	50	41	57	36	31	25	18	13	14
Tax %	24	27	34	30	26	31	25	28	36	26	23	26	31	37
Net Profit	57	29	21	28	39	35	31	41	23	23	19	13	9	9
Net Profit Growth %	96.6%	38.1%	-25%	-28.2%	11.4%	12.9%	-24.4%	78.3%	-	21.1%	46.2%	44.4%	-	-
EPS in Rs	65.41	32.31	22.21	31.3	46.22	40.47	34.29	48.87	30.12	27.68	22.57	15.99	11.11	10.89
Dividend Payout %	17	22	27	26	22	25	19	23	33	19	18	19	18	18

Cash Flows

	Mar 2026	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019	Mar 2018	Mar 2017	Mar 2016	Mar 2015	Mar 2014	Mar 2013
Cash from Operating Activity	64	65	48	24	9	58	37	47	38	35	19	20	9	12
Cash from Investing Activity	-3	-20	-22	-77	-117	-42	-73	-21	-26	-30	-13	-21	-15	-23
Cash from Financing Activity	-49	-52	-26	42	112	-18	19	3	-11	2	-7	7	7	10
Net Cash Flow	12	-7	0	-12	3	-2	-17	28	1	6	-1	5	2	-1

Balance Sheet

	Mar 2026	Sep 2025	Mar 2025	Sep 2024	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019	Mar 2018	Mar 2017	Mar 2016	Mar 2015	Mar 2014	Mar 2013
Equity Capital	9	9	9	9	9	9	9	9	9	9	9	9	9	9	9	9
Reserves	352	329	306	293	283	271	251	220	193	169	132	113	93	76	66	59
Borrowings	195	214	213	244	244	274	228	110	121	90	69	66	59	55	48	32
Other Liabilities	123	124	126	123	126	116	74	73	65	32	35	25	25	20	19	24
Total Liabilities	678	675	653	669	662	670	562	411	387	299	244	213	186	160	142	124
Fixed Assets	421	247	233	239	240	259	237	133	142	145	110	102	65	60	54	38
CWIP	0	182	183	171	171	149	82	109	74	7	32	21	36	33	21	29
Investments	43	37	34	32	30	25	21	0	0	0	0	0	0	0	0	0
Other Assets	215	209	203	228	221	237	222	169	170	148	102	89	85	68	68	57
Total Assets	678	675	653	669	662	670	562	411	387	299	244	213	186	160	142	124

Delivery

Delivery Data: HESTERBIO

#	Date	2067 30% 2684	Value (Cr)	Q/T 15	Del 38	Del 12
1	4-Sep	2405	23	11	11	3
2	3-Sep	2202	0	6	44	0
3	2-Sep	2176	2	8	52	1
4	1-Sep	2200	1	7	67	1
5	31-Aug	2259	0	5	62	0
6	28-Aug	2302	1	4	51	0
7	27-Aug	2290	1	6	67	1
8	26-Aug	2354	1	7	52	1
9	25-Aug	2422	1	5	50	0
10	24-Aug	2364	0	5	64	0
11	21-Aug	2368	1	7	69	1
12	20-Aug	2413	0	5	61	0
13	19-Aug	2412	1	6	65	1
14	18-Aug	2451	1	5	38	1
15	17-Aug	2418	1	4	54	0
16	14-Aug	2414	1	5	60	1
17	13-Aug	2461	1	4	54	0
18	12-Aug	2465	1	6	41	1
19	11-Aug	2488	2	6	42	1
20	10-Aug	2494	3	7	39	1
21	7-Aug	2418	1	5	38	1
22	6-Aug	2458	1	7	48	0
23	5-Aug	2433	1	5	49	1
24	4-Aug	2482	1	6	39	1
25	3-Aug	2442	2	5	53	1
26	31-Jul	2478	3	5	32	1
27	30-Jul	2478	114	9	8	9
28	29-Jul	2497	2	5	57	1
29	28-Jul	2520	3	9	61	2
30	27-Jul	2528	10	7	37	4
31	24-Jul	2367	2	7	53	1
32	23-Jul	2365	2	5	58	1
33	22-Jul	2431	2	5	33	1
34	21-Jul	2450	4	6	40	2
35	20-Jul	2523	13	7	26	3
36	17-Jul	2448	4	8	51	2
37	16-Jul	2438	8	10	48	4
38	15-Jul	2412	24	10	30	7
39	14-Jul	2387	73	10	18	13
40	13-Jul	2545	120	26	20	23
41	10-Jul	2121	1	8	63	0
42	9-Jul	2102	1	4	49	0
43	8-Jul	2088	2	6	64	1
44	7-Jul	2206	1	5	61	1
45	6-Jul	2168	1	6	63	0
46	3-Jul	2198	2	6	41	1
47	2-Jul	2167	0	4	55	0
48	1-Jul	2199	1	5	55	1
49	30-Jun	2166	1	5	50	0
50	29-Jun	2199	3	7	52	2

Daily Market Cap

Date	Total Market Cap	Change	Chg %
04-Sep	2,020c	147c	7.86
03-Sep	1,873c	10c	0.52
01-Sep	1,883c	61c	3.14
31-Aug	1,944c	13c	0.64
27-Aug	1,957c	94c	4.56
26-Aug	2,050c	33c	1.64
25-Aug	2,017c	10c	0.47
24-Aug	2,008c	43c	2.07
21-Aug	2,050c	9c	0.42
19-Aug	2,042c	12c	0.56
18-Aug	2,053c	7c	0.35
17-Aug	2,046c	3c	0.17
14-Aug	2,043c	27c	1.32
13-Aug	2,070c	44c	2.09
12-Aug	2,114c	13c	0.61
11-Aug	2,127c	26L	0.01
10-Aug	2,127c	76c	3.72
07-Aug	2,050c	15c	0.72
06-Aug	2,065c	10c	0.46
05-Aug	2,075c	12c	0.57
04-Aug	2,063c	9L	0.00
03-Aug	2,063c	23c	1.10
31-Jul	2,086c	58c	2.71
30-Jul	2,144c	35c	1.67
29-Jul	2,109c	20c	0.92
28-Jul	2,128c	34c	1.57
27-Jul	2,162c	151c	7.48
24-Jul	2,012c	0	0

Stock Checklist

Price is above from 52 week high low average: 79%

Stock is trading above all short term SMAs: YES

Stock is trading above all long term SMAs: YES

Stock is Consistently Improving Long Term: NO

FII purchased in last quarter: NO

Promoters are buying the stock: NO

Mutual Fund Holdings

Held by 2 fund scheme(s) across 1 fund house(s) as of Aug26 · Total value ₹0 Cr · 0 increasing / 0 decreasing · View in MF Pro →

Fund House	Schemes	Weight %	Change	Value (Cr)
Bandhan Mutual Fund	2	0.05%	+0.01%	0

Hester Biosciences Limited

Price Chart

Price Performance

Moving Average

PIVOT LEVEL

Competitors/Peers

Shareholding Pattern (%)

Quarterly Results

Profit and Loss

Cash Flows

Balance Sheet

Delivery

Daily Market Cap

Stock Checklist

Mutual Fund Holdings

Strategy Builder

Bulk Deals

Events

News

Exchange Filings

Annual Reports

Ratings & Research Reports

Concalls

Announcements